- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Nicole Rosendale Says Data Collection Is Step 1 for Value-Based Care in the Neurology Space for LGBTQ+ Individuals
Nicole Rosendale, MD, assistant professor of neurology at the University of California San Francisco, neurologist/neurohospitalist, talks about how data on the LGBTQ+ community in the neurology space is needed in order to provide effective value-based health care.
More data is needed in order to provide true value-based care to LGBTQ+ community memebers, says Nicole Rosendale, MD, assistant professor of neurology at the University of California San Francisco, neurologist/neurohospitalist.
Transcript
How can value-based health care methods help the LGBTQ+ community in the neurology space?
This is such an important question, and I think the idea of value-based care has a lot of momentum behind it. The challenge is that value-based care requires data. It requires measurement of outcomes; reporting back continual iteration of the process to improve the quality of care. The challenge is with that measurement piece, and so not very many folks collect sexual orientation or gender identity in their data routinely. So, we don't have that first part; we don't have the data to go into the process, to talk about outcomes, to talk about how we can do better for service for the community and access and outcomes within care. So, I think that really working on that first step is going to hopefully drive us towards be able to actually provide value-based care for LGBTQ individuals.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
The Push for Fair Pricing and Reform in Pharmacy Benefit Management
April 3rd 2025Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to enhance transparency, reduce patient costs, and navigate the evolving healthcare landscape.
Read More
How Pharmacy Deserts, Biosimilars, and Market Trends Are Shaping Managed Care
April 2nd 2025Rising biosimilar adoption, shifting market dynamics, and escalating supply chain vulnerabilities are driving change in managed care, creating both challenges and opportunities for stakeholders, as explored by speakers at the Academy of Managed Care Pharmacy’s annual meeting.
Read More
Robert F. Kennedy Jr Faces Senate Inquiry Over Deep Cuts to HHS Impacting FDA, CDC, NIH, CMS
April 2nd 2025A bipartisan letter from lawmakers questions the legality of Robert F. Kennedy Jr's HHS changes and the lack of clear communication regarding their potential impact on American health.
Read More
